{"id":"W2949352054","doi":"10.1007/s12325-019-00994-7","title":"Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE)","year":2019,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Astellas Pharma Global Development; Astellas Pharma","keywords":"Mirabegron; Medicine; Overactive bladder; Quality of life (healthcare); Internal medicine; Adverse effect; Prospective cohort study; Discontinuation; Intensive care medicine; Urology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002884822,0.0001759911,0.0004827241,0.0005558869,0.0002649902,0.000788474,0.0002713212,0.000392585,0.001008686],"category_scores_gemma":[0.007268322,0.0001577487,0.0009253218,0.001412023,0.0001985212,0.000638463,0.0004454746,0.0006306526,0.0001654427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002249631,"about_ca_system_score_gemma":0.0004889309,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008875309,"about_ca_topic_score_gemma":0.001186946,"domain_scores_codex":[0.997638,0.001098075,0.0004288551,0.000331174,0.0003352216,0.0001686792],"domain_scores_gemma":[0.9895703,0.001785228,0.007150073,0.0005118274,0.000531913,0.0004507364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004620456,0.00009316251,0.9970347,0.00003741547,0.000170127,0.00003622916,0.0000597974,0.00005947793,0.000103675,0.00001283217,0.0001244476,0.001806155],"study_design_scores_gemma":[0.00004608014,0.0006065991,0.9985153,0.00001213672,0.0001333074,0.0001618429,0.0001069839,0.0001422354,0.0000731582,0.00001050877,0.00018555,0.000006149335],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980566,0.0003624556,0.0001288552,0.00007885538,0.000006603519,0.00002965677,0.000929506,0.000004707182,0.0004026859],"genre_scores_gemma":[0.9986686,0.0001562516,0.0001308302,0.00005098228,0.00001614484,0.00003930673,0.000874988,0.000001948814,0.00006097685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002884822,"threshold_uncertainty_score":0.01525658,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04144466604187597,"score_gpt":0.3651091090916884,"score_spread":0.3236644430498124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}